Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Breast Cancer

Free Subscription 21.01.2019 1 Ann Surg Oncol 4 BMC Cancer 1 Breast Cancer (Dove Med Press) 3 Breast Cancer Res 1 Breast Cancer Res Treat 1 Cancer 1 Cancer Cell 2 Cancer Epidemiol Biomarkers Prev 1 Cancer Res 1 Clin Breast Cancer 3 Clin Cancer Res 1 Eur J Cancer 3 Eur J Surg Oncol 1 Gene 1 J Natl Cancer Inst 2 Oncogene 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Surg Oncol

1. MERRILL AY, Ochoa D, Klimberg VS, Hill EL, et al
   Cutting Healthcare Costs with Hematoma-Directed Ultrasound-Guided Breast Lumpectomy.
   Ann Surg Oncol. 2018;25:3076-3081.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

2. BORGQUIST S, Broberg P, Tojjar J, Olsson H, et al
   Statin use and breast cancer survival - a Swedish nationwide study.
   BMC Cancer. 2019;19:54.
   PubMed     Text format     Abstract available
   
   
3. KHODABANDEHLOU N, Mostafaei S, Etemadi A, Ghasemi A, et al
   Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins.
   BMC Cancer. 2019;19:61.
   PubMed     Text format     Abstract available
   
   
4. KIRKHAM AA, Ian Paterson D, Prado CM, Mackey JR, et al
   Correction to: Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer.
   BMC Cancer. 2019;19:75.
   PubMed     Text format     Abstract available
   
   
5. JEVRIC M, Matic IZ, Krivokuca A, Dordic Crnogorac M, et al
   Association of uPA and PAI-1 tumor levels and 4G/5G variants of PAI-1 gene with disease outcome in luminal HER2-negative node-negative breast cancer patients treated with adjuvant endocrine therapy.
   BMC Cancer. 2019;19:71.
   PubMed     Text format     Abstract available
   
   

   
   Breast Cancer (Dove Med Press)

6. ANTOLIN S, Acea B, Albaina L, Concha A, et al
   Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution.
   Breast Cancer (Dove Med Press). 2018;11:29-42.
   PubMed     Text format     Abstract available
   
   

   
   Breast Cancer Res

7. GAO C, Xiao G, Piersigilli A, Gou J, et al
   Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells.
   Breast Cancer Res. 2019;21:5.
   PubMed     Text format     Abstract available
   
   
8. HOFFMAN J, Fejerman L, Hu D, Huntsman S, et al
   Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas.
   Breast Cancer Res. 2019;21:3.
   PubMed     Text format     Abstract available
   
   
9. KIJEWSKA M, Viski C, Turrell F, Fitzpatrick A, et al
   Using an in-vivo syngeneic spontaneous metastasis model identifies ID2 as a promoter of breast cancer colonisation in the brain.
   Breast Cancer Res. 2019;21:4.
   PubMed     Text format     Abstract available
   
   

   
   Breast Cancer Res Treat

10. FRIEDLAENDER A, Vuilleumier A, Viassolo V, Ayme A, et al
    BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients.
    Breast Cancer Res Treat. 2019 Jan 11. pii: 10.1007/s10549-018-05127.
    PubMed     Text format     Abstract available
    
    

    
    Cancer

11. BEDROSIAN I, Parker PA, Brewster AM
    Who should get a contralateral prophylactic mastectomy for breast cancer?
    Cancer. 2019 Jan 15. doi: 10.1002/cncr.31915.
    PubMed     Text format    
    
    

    
    Cancer Cell

12. ISHAY-RONEN D, Diepenbruck M, Kalathur RKR, Sugiyama N, et al
    Gain Fat-Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis.
    Cancer Cell. 2019;35:17-32.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Epidemiol Biomarkers Prev

13. DUPRE NC, Hart JE, Holmes MD, Poole EM, et al
    Particulate Matter and Traffic-related Exposures in Relation to Breast Cancer Survival.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 15. pii: 1055-9965.EPI-18-0803.
    PubMed     Text format     Abstract available
    
    
14. DECKER B, Allen J, Luccarini C, Pooley KA, et al
    Targeted resequencing of the coding sequence of 38 genes near breast cancer GWAS loci in a large case-control study.
    Cancer Epidemiol Biomarkers Prev. 2019 Jan 14. pii: 1055-9965.EPI-18-0298.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

15. MAZIVEYI M, Dong S, Baranwal S, Mehrnezhad A, et al
    Exosomes from Nischarin-Expressing Cells Reduce Breast Cancer Cell Motility and tumor growth.
    Cancer Res. 2019 Jan 11. pii: 0008-5472.CAN-18-0842.
    PubMed     Text format     Abstract available
    
    

    
    Clin Breast Cancer

16. VERNIERI C, Prisciandaro M, Milano M, Cona MS, et al
    Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles.
    Clin Breast Cancer. 2018 Dec 12. pii: S1526-8209(18)30638.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

17. CLARK AS, McAndrew NP, Troxel A, Feldman M, et al
    Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer.
    Clin Cancer Res. 2019 Jan 11. pii: 1078-0432.CCR-18-0790.
    PubMed     Text format     Abstract available
    
    
18. CROSBY EJ, Gwin WR, Blackwell K, Marcom PK, et al
    Vaccine-induced memory CD8+ T cells provide clinical benefit in HER2 expressing breast cancer: a mouse to human translational study.
    Clin Cancer Res. 2019 Jan 11. pii: 1078-0432.CCR-18-3102.
    PubMed     Text format     Abstract available
    
    
19. BERGEN ES, Berghoff AS, Medjedovic M, Rudas M, et al
    Continued endocrine therapy is associated with improved survival in patients with breast cancer brain metastases.
    Clin Cancer Res. 2019 Jan 15. pii: 1078-0432.CCR-18-1968.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

20. LIVI L, Scotti V, Desideri I, Saieva C, et al
    Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial.
    Eur J Cancer. 2019;108:100-110.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

21. RUBIO IT, Wyld L, Esgueva A, Kovacs T, et al
    Variability in breast cancer surgery training across Europe: An ESSO-EUSOMA international survey.
    Eur J Surg Oncol. 2019 Jan 5. pii: S0748-7983(19)30003.
    PubMed     Text format     Abstract available
    
    
22. BRAHMA B, Yamamoto T
    Breast cancer treatment-related lymphedema (BCRL): An overview of the literature and updates in microsurgery reconstructions.
    Eur J Surg Oncol. 2019 Jan 4. pii: S0748-7983(19)30004.
    PubMed     Text format     Abstract available
    
    
23. VAN EGDOM LSE, Lagendijk M, van der Kemp MH, van Dam JH, et al
    Implementation of Value Based Breast Cancer Care.
    Eur J Surg Oncol. 2019 Jan 4. pii: S0748-7983(19)30007.
    PubMed     Text format     Abstract available
    
    

    
    Gene

24. ZHONG C, Mai Y, Gao H, Zhou W, et al
    Mitochondrial targeting of TR3 is involved in TPA induced apoptosis in breast cancer cells.
    Gene. 2019 Jan 11. pii: S0378-1119(19)30032-0. doi: 10.1016/j.gene.2018.
    PubMed     Text format     Abstract available
    
    

    
    J Natl Cancer Inst

25. PAREJA F, Lee JY, Brown DN, Piscuoglio S, et al
    The Genomic Landscape of Mucinous Breast Cancer.
    J Natl Cancer Inst. 2019 Jan 11. pii: 5288408. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

26. MANN J, Githaka JM, Buckland TW, Yang N, et al
    Non-canonical BAD activity regulates breast cancer cell and tumor growth via 14-3-3 binding and mitochondrial metabolism.
    Oncogene. 2019 Jan 11. pii: 10.1038/s41388-018-0673.
    PubMed     Text format     Abstract available
    
    
27. PANAGOPOULOU M, Karaglani M, Balgkouranidou I, Biziota E, et al
    Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers.
    Oncogene. 2019 Jan 14. pii: 10.1038/s41388-018-0660.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

28. MORGAT C, Schollhammer R, Macgrogan G, Barthe N, et al
    Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.
    PLoS One. 2019;14:e0210905.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: